Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Outpatients With COVID-19
NCT04784754Phase 2Withdrawn
- Sponsor
- University at Buffalo
- Start
- Apr 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in coronavirus disease 2019 (COVID-19), sponsored by University at Buffalo. Planned start Apr 2021; status: withdrawn.
02
Drugs
melatonin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04784754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04784754.